1044 related articles for article (PubMed ID: 26285657)
1. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
2. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives.
Zhao L; Teklemariam T; Hantash BM
Stem Cell Res; 2014 Sep; 13(2):342-54. PubMed ID: 25218797
[TBL] [Abstract][Full Text] [Related]
3. Functional disruption of human leukocyte antigen II in human embryonic stem cell.
Chen H; Li Y; Lin X; Cui D; Cui C; Li H; Xiao L
Biol Res; 2015 Oct; 48():59. PubMed ID: 26506955
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.
Deuse T; Seifert M; Tyan D; Tsao PS; Hua X; Velden J; Eiermann T; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
J Cell Sci; 2011 Sep; 124(Pt 17):3029-37. PubMed ID: 21878509
[TBL] [Abstract][Full Text] [Related]
5. Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection.
Shao L; Zhang Y; Pan X; Liu B; Liang C; Zhang Y; Wang Y; Yan B; Xie W; Sun Y; Shen Z; Yu XY; Li Y
Cell Mol Life Sci; 2020 Mar; 77(5):937-952. PubMed ID: 31312880
[TBL] [Abstract][Full Text] [Related]
6. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
[TBL] [Abstract][Full Text] [Related]
7. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
[TBL] [Abstract][Full Text] [Related]
8. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.
Gornalusse GG; Hirata RK; Funk SE; Riolobos L; Lopes VS; Manske G; Prunkard D; Colunga AG; Hanafi LA; Clegg DO; Turtle C; Russell DW
Nat Biotechnol; 2017 Aug; 35(8):765-772. PubMed ID: 28504668
[TBL] [Abstract][Full Text] [Related]
9. HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.
Karabekian Z; Ding H; Stybayeva G; Ivanova I; Muselimyan N; Haque A; Toma I; Posnack NG; Revzin A; Leitenberg D; Laflamme MA; Sarvazyan N
Tissue Eng Part A; 2015 Oct; 21(19-20):2559-71. PubMed ID: 26218149
[TBL] [Abstract][Full Text] [Related]
10. Generation of Retinal Pigment Epithelial Cells Derived from Human Embryonic Stem Cells Lacking Human Leukocyte Antigen Class I and II.
Petrus-Reurer S; Winblad N; Kumar P; Gorchs L; Chrobok M; Wagner AK; Bartuma H; Lardner E; Aronsson M; Plaza Reyes Á; André H; Alici E; Kaipe H; Kvanta A; Lanner F
Stem Cell Reports; 2020 Apr; 14(4):648-662. PubMed ID: 32197113
[TBL] [Abstract][Full Text] [Related]
11. Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives.
Chen HF; Yu CY; Chen MJ; Chou SH; Chiang MS; Chou WH; Ko BS; Huang HP; Kuo HC; Ho HN
Cell Transplant; 2015; 24(5):845-64. PubMed ID: 24144439
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.
Deuse T; Seifert M; Phillips N; Fire A; Tyan D; Kay M; Tsao PS; Hua X; Velden J; Eiermann T; Volk HD; Reichenspurner H; Robbins RC; Schrepfer S
Circulation; 2011 Sep; 124(11 Suppl):S3-9. PubMed ID: 21911816
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Immunological Tolerance by HLA-G1 from Neural Progenitor Cells (NPCs) Derived from Human Embryonic Stem Cells (hESCs).
Zhao HX; Jiang F; Zhu YJ; Wang L; Li K; Li Y; Wang XH; Li LS; Yao YQ
Cell Physiol Biochem; 2017; 44(4):1435-1444. PubMed ID: 29186714
[TBL] [Abstract][Full Text] [Related]
14. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
[TBL] [Abstract][Full Text] [Related]
15. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
[TBL] [Abstract][Full Text] [Related]
16. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.
D'Urso CM; Wang ZG; Cao Y; Tatake R; Zeff RA; Ferrone S
J Clin Invest; 1991 Jan; 87(1):284-92. PubMed ID: 1898655
[TBL] [Abstract][Full Text] [Related]
17. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
Wang Z; Arienti F; Parmiani G; Ferrone S
Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
[TBL] [Abstract][Full Text] [Related]
18. HLA engineering of human pluripotent stem cells.
Riolobos L; Hirata RK; Turtle CJ; Wang PR; Gornalusse GG; Zavajlevski M; Riddell SR; Russell DW
Mol Ther; 2013 Jun; 21(6):1232-41. PubMed ID: 23629003
[TBL] [Abstract][Full Text] [Related]
19. Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies.
Ji TT; Niu SS; Fang MH; Xu LX; Wang X; Zou J; Xu F; Zhang M; Niu R; Wu J; Wang L; Li ZK; Yang YG; Hao J; Li W; Hu Z; Zhou Q
Cell Prolif; 2023 May; 56(5):e13471. PubMed ID: 37199039
[TBL] [Abstract][Full Text] [Related]
20. T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids.
Gaykema LH; van Nieuwland RY; Lievers E; Moerkerk WBJ; de Klerk JA; Dumas SJ; Kers J; Zaldumbide A; van den Berg CW; Rabelink TJ
Stem Cells Transl Med; 2024 Jan; 13(1):69-82. PubMed ID: 37843402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
